Superoxide Dismutase and Lipid Peroxidation in Acute Lymphocytic Leukemia
Keywords:
-Abstract
There is much evidence suggesting a possible role of reactive oxygen species and other free radicals as mediators of phenotypic and genotypic changes that lead from mutation to cancer. The imbalance in cancer cell antioxidant defense mechanism can influence also the sensitivity to cytoreductive therapy. In erythrocytes, it can result in hemolysis which is one of the pathogenic mechanisms of anemia in cancer patients. Parameters of lipid peroxidation (malondialdehyde, MDA) and antioxidant enzymes here represented by superoxide dismutase (SOD) have been investigated in acute lymphocytic leukemia. Twenty patients of various stages and activities of the disease and twenty five normal controls were recruited. Significantly higher concentrations of total MDA in plasma (28.10 ± 2.90 nmol/L vs. 9.20 ± 0.30 nmol/L, p < 0.0001) as well as in erythrocytes (3.00 ± 0.20 nmol/gHb vs. 1.20 ± 0.10 nmol/gHb, p < 0.0001) were found compared to the control group. Significantly lower activity of SOD (1,966 ± 110 U/gHb vs. 3,095 ± 60 U/gHb, p < 0.0001) was also observed. No correlations were obtained between SOD activity, MDA concentration in both red cells and plasma with blast cell count and hemoglobin concentration. This study suggests that free radicals are associated with an impaired antioxidant defense enzyme activity resulting in increased lipid peroxidation in acute lymphocytic leukemia.
Downloads
Published
How to Cite
Issue
Section
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.